1-3 of 3
Clinical Research Coordinator
Close
Sort by
Journal Articles

The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Wael A. Harb, MD, Nehal Lakhani, MD PhD, Ana Logsdon, LPN, Clinical Research Coordinator, Mary Steigelman, RN, Heidi Smith-Green, BSN, RN, Shari Gaylor, RN, Wendi Rodrigueza, PhD, Michael Woolliscroft, BA, MBA, Mina Sooch, BS, MBA, Richard A. Messmann, MD MHS, MSc, Ayad Al-Katib, MD FACP
Journal: Blood
Blood (2014) 124 (21): 1716.
https://doi.org/10.1182/blood.V124.21.1716.1716
Published: 2014
Journal Articles

The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active In Patients With Relapsed Or Refractory Non-Hodgkin’s Lymphoma

Wael A. Harb, MD, Nehal Lakhani, MD, PhD, Ana Logsdon, LPN, Clinical Research Coordinator, Mary Steigelman, RN, Heidi Smith-Green, BSN, RN, Shari Gaylor, RN, Michael Woolliscroft, BA, MBA, Wendi Rodrigueza, Ph.D., Mina Sooch, BS, MBA, Richard A. Messmann, MD, MHS, MSc, Ayad Al-Katib, MD, FACP
Journal: Blood
Blood (2013) 122 (21): 88.
https://doi.org/10.1182/blood.V122.21.88.88
Published: 2013
Journal Articles

Normal Serum-Erythropoietin (S-epo) Level at Diagnosis of Polycythemia Vera (PV) Correlates with LowJAK2 V617F Mutant Allele Burden and Indicates Mild Phenotype.

Joshua J. Goldman, Katherine Vandris, Clinical, Research, Coordinator, Fernando Adriano, Clinical, Research, Nurse, Michael Bourla, Clinical, Research, Coordinator, Richard T. Silver, MD
Journal: Blood
Blood (2009) 114 (22): 4978.
https://doi.org/10.1182/blood.V114.22.4978.4978
Published: 2009